EuroEyes Expands European Operations with Strategic Acquisitions
EuroEyes International Eye Clinic Limited (HK:1846) has announced strategic acquisitions in Switzerland and the UK, acquiring medical clinics and assets for refractive surgery valued at CHF12,010,000 and CHF200,000, respectively. These transactions are discloseable under Hong Kong Stock Exchange Listing Rules, marking a significant expansion in EuroEyes' operational capacity in Europe. The latest analyst rating for HK:1846 is a Hold with a price target of HK$3.50. EuroEyes specializes in eye care and corrective surgeries, with a current market cap of HK$943.3M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from EuroEyes International Eye Clinic Limited ( (HK:1846) ).
EuroEyes International Eye Clinic Limited has announced the acquisition of assets in Switzerland and the United Kingdom through its subsidiaries. The acquisitions include medical clinics and related assets for refractive surgery, with the Swiss assets valued at CHF12,010,000 and the UK assets at CHF200,000. These transactions are considered discloseable under the Hong Kong Stock Exchange Listing Rules, indicating a strategic expansion in EuroEyes’ operational capacity and market presence in Europe.
The most recent analyst rating on (HK:1846) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on EuroEyes International Eye Clinic Limited stock, see the HK:1846 Stock Forecast page.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited operates in the healthcare industry, focusing on providing refractive surgery services. The company specializes in eye care, particularly in corrective eye surgeries, and has a market presence in Europe, including Switzerland and the United Kingdom.
Average Trading Volume: 166,536
Technical Sentiment Signal: Sell
Current Market Cap: HK$943.3M
Find detailed analytics on 1846 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- CAPR Lawsuit Alert! Class Action Lawsuit Against Capricor Therapeutics
- META or GOOGL: Top Analyst Picks the ‘Top Consumer AI Play’
- Tesla Cuts New Model 3 Prices by 4% in China, While Norway Sales Surge 38%
Disclaimer & DisclosureReport an Issue
